Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Coloplast A/S
  6. Summary
    COLO B   DK0060448595

COLOPLAST A/S

(COLO B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
994(c) 968.2(c) 981.4(c) 972.4(c) 982.2(c) Last
255 149 345 515 174 953 228 382 188 386 Volume
+1.18% -2.60% +1.36% -0.92% +1.01% Change
More quotes
Financials
Sales 2021 19 434 M 3 166 M 3 166 M
Net income 2021 4 779 M 778 M 778 M
Net Debt 2021 1 871 M 305 M 305 M
P/E ratio 2021 43,8x
Yield 2021 1,96%
Sales 2022 21 031 M 3 426 M 3 426 M
Net income 2022 5 218 M 850 M 850 M
Net Debt 2022 1 883 M 307 M 307 M
P/E ratio 2022 39,9x
Yield 2022 2,15%
Capitalization 209 B 34 001 M 34 035 M
EV / Sales 2021 10,8x
EV / Sales 2022 10,0x
Nbr of Employees 12 500
Free-Float 57,4%
More Financials
Company
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (46.7%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (40.6%): bags and equipment used following intestinal operations; - wound care and skincare products (12.7%): wound dressings, bandages, creams and... 
Read more
More about the company
Ratings of Coloplast A/S
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about COLOPLAST A/S
06/07COLOPLAST A/S  : - Transactions in connection with share buy-back programme, wee..
AQ
05/31COLOPLAST A/S  : - Transactions in connection with share buy-back programme, wee..
AQ
05/25COLOPLAST A/S  : - Transactions in connection with share buy-back programme, wee..
AQ
05/21CORRECTION : Coloplast A/S - Trading in Coloplast shares by board members, execu..
AQ
05/17COLOPLAST A/S  : - Transactions in connection with share buy-back programme, wee..
AQ
05/11COLOPLAST A/S  : - Trading in Coloplast shares by board members, executives or a..
AQ
05/10COLOPLAST A/S  : - Transactions in connection with share buy-back programme, wee..
AQ
05/10COLOPLAST A/S : Ex-dividend day for interim dividend
FA
05/06COLOPLAST A/S  : Fiscal H1 Net Profit Grows Thanks To Solid Performance In Emerg..
MT
05/06COLOPLAST A/S  : H1 2020/21 roadshow presentation
PU
05/06COLOPLAST A/S  : H1 2020/21 Interim Financial Report
PU
05/06COLOPLAST A/S  : delivers 2% organic growth in Q2 as well as an EBIT margin of 3..
AQ
05/06COLOPLAST A/S  : - Announcement no. 03/2021 – Interim Financial Report, H1..
AQ
05/06COLOPLAST A/S  : Half-year results
CO
05/03COLOPLAST A/S  : - Transactions in connection with share buy-back programme, wee..
AQ
More news
News in other languages on COLOPLAST A/S
05/17AVIS D'ANALYSTES DU JOUR  : Amundi, Ubisoft, Icade, Pirelli, Avast, Drax, Just E..
05/17STOCK MARKET PARIS : Les actions tiennent, les cryptomonnaies décrochent
04/13DGAP-NAV : Effecten-Spiegel AG: Net Asset Value
02/05Au beau fixe
02/05AVIS D'ANALYSTES DU JOUR  : Dassault Systèmes, Nokia, Icade, Klépierre, Burberry..
More news
Analysis
Global equities rally as more U.S. stimulus looms, silver slides
Chart COLOPLAST A/S
Duration : Period :
Coloplast A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COLOPLAST A/S
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 985,06 DKK
Last Close Price 982,20 DKK
Spread / Highest target 17,1%
Spread / Average Target 0,29%
Spread / Lowest Target -18,6%
EPS Revisions
Managers and Directors
NameTitle
Kristian Villumsen President & Chief Executive Officer
Anders Lonning-Skovgaard Chief Financial Officer & Executive Vice President
Lars Søren Rasmussen Chairman
Oliver Johansen Senior VP-Global Research & Development
Allan Rasmussen Executive Vice President-Global Operations
Sector and Competitors
1st jan.Capitalization (M$)
COLOPLAST A/S5.66%34 001
TELEFLEX INCORPORATED-4.38%18 391
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED1.60%10 373
TOP GLOVE CORPORATION BHD.-22.88%9 191
HARTALEGA HOLDINGS-31.63%6 903
INTCO MEDICAL TECHNOLOGY CO., LTD.0.00%5 700